Patent details
EP2481402
Title:
Nanoparticle comprising rapamycin and albumin as anticancer agent
Basic Information
- Publication number:
- EP2481402
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP121524557
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Nanoparticle comprising rapamycin and albumin as anticancer agent
- French Title of Invention:
- Nanoparticule comportant du rapamycine et albumine en tant qu'agent anti-cancer
- German Title of Invention:
- Nanopartikel mit Rapamycin und Albumin als Antikrebsmittel
- SPC Number:
-
Dates
- Filing date:
- 07/03/2008
- Grant date:
- 09/05/2018
- EP Publication Date:
- 01/08/2012
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/05/2018
- EP B1 Publication Date:
- 09/05/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 07/03/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/05/2018
-
-
- Name:
- Abraxis BioScience, LLC
- Address:
- 86 Morris Avenue, Summit, NJ 07901, United States (US)
Agent
- Name:
- VALIPAT
- From:
- 12/07/2018
- Address:
- Uitbreidingstraat 72-5, 2600, Antwerp, Belgium (BE)
- To:
Inventor
1
- Name:
- Trieu, Vuong
- Address:
- United States (US)
2
- Name:
- Desai, Neil, P.
- Address:
- United States (US)
3
- Name:
- Soon-Shiong, Patrick
- Address:
- United States (US)
Priority
1
- Priority Number:
- 905735 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
2
- Priority Number:
- 905669 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
3
- Priority Number:
- 905767 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
4
- Priority Number:
- 905734 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
5
- Priority Number:
- 905663 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
6
- Priority Number:
- 905672 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
7
- Priority Number:
- 905750 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
8
- Priority Number:
- 905662 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
9
- Priority Number:
- 905787 P
- Priority Date:
- 07/03/2007
- Priority Country:
- United States (US)
10
- Priority Number:
- 923248 P
- Priority Date:
- 13/04/2007
- Priority Country:
- United States (US)
11
- Priority Number:
- 923456 P
- Priority Date:
- 13/04/2007
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 9/19;
A61K 9/51;
A61K 31/436;
A61K 31/517;
A61K 31/685;
A61K 31/704;
A61P 35/00;
Publication
European Patent Bulletin
- Issue number:
- 201819
- Publication date:
- 09/05/2018
- Description:
- Grant (B1)
Deed
Power of attorney
- Change Kind/ Decision Type:
- Assignment
- Deed Number:
- RC20180000240A
- Date Registered:
- 12/07/2018
- Licence Effective Date:
-
- Licence Expiration Date:
-
- Scope of Licence:
-
- Deed Filer:
-
VALIPAT
- Journal Edition Number:
-
- Text:
-
- Country Code:
-
- Updated Licence Number:
-
- Terminated Licence Number:
-
Removed Pledgee
- Name:
-
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/03/2026
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 281 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 27/02/2025
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM